Literature DB >> 10428435

Interferon beta-1b and childhood multiple sclerosis.

A B Adams1, W R Tyor, K R Holden.   

Abstract

The long-term treatment with interferon beta-1b of a 7-year-old male with relapsing-remitting multiple sclerosis is documented. Thirty-two months after initiating treatment, he demonstrates dramatic clinical improvement, without relapse, despite high titers of neutralizing antibodies to interferon beta-1b. It appears reasonable to attribute a role in his improvement to interferon beta-1b.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10428435     DOI： 10.1016/s0887-8994(99)00007-7

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN： 0887-8994            Impact factor:   3.372


  8 in total

1.  Pediatric multiple sclerosis.

Authors:  Yashma Patel; Vikram Bhise; Lauren Krupp
Journal:  Ann Indian Acad Neurol       Date:  2009-10       Impact factor: 1.383

Review 2.  Multiple sclerosis in childhood and adolescence: clinical features and management.

Authors:  O Pinhas-Hamiel; I Sarova-Pinhas; A Achiron
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

3.  Effect of Dimethyl Fumarate vs Interferon β-1a in Patients With Pediatric-Onset Multiple Sclerosis: The CONNECT Randomized Clinical Trial.

Authors:  Patrick Vermersch; Matthew Scaramozza; Seth Levin; Raed Alroughani; Kumaran Deiva; Carlo Pozzilli; Jennifer Lyons; Oksana Mokliatchouk; Joe Pultz; Fatou N'Dure; Shifang Liu; Runda Badwan; Filipe Branco; Valencia Hood-Humphrey; Nathalie Franchimont; Jerome Hanna; Amir-Hadi Maghzi
Journal:  JAMA Netw Open       Date:  2022-09-01

Review 4.  Pediatric multiple sclerosis.

Authors:  Brenda L Banwell
Journal:  Curr Neurol Neurosci Rep       Date:  2004-05       Impact factor: 5.081

Review 5.  Pediatric multiple sclerosis.

Authors:  Dorothée Chabas; Ari J Green; Emmanuelle Waubant
Journal:  NeuroRx       Date:  2006-04

6.  Treatment of Pediatric Multiple Sclerosis.

Authors:  Lauren B Krupp; William S Macallister
Journal:  Curr Treat Options Neurol       Date:  2005-05       Impact factor: 3.972

7.  Interferon beta-1b in treatment-naïve paediatric patients with relapsing-remitting multiple sclerosis: Two-year results from the BETAPAEDIC study.

Authors:  Jutta Gärtner; Wolfgang Brück; Almuth Weddige; Hannah Hummel; Christiane Norenberg; Jörg-Peter Bugge
Journal:  Mult Scler J Exp Transl Clin       Date:  2017-12-26

8.  Internuclear Ophthalmoplegia as the First Manifestation of Pediatric-Onset Multiple Sclerosis and Concurrent Lyme Disease.

Authors:  Jonathan Chao; Sandal Saleem; Hassan N Tausif; Kelly Levasseur; Lori A Stec
Journal:  Am J Case Rep       Date:  2020-10-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.